(Presentation) Due present at the ASCO GU meeting in February
(Presentation) Presented at the 2014 NCI Investor Forum, a competitive showcase of the NIH’s best portfolio companies in the cancer space, with attendance by representatives from major VC’s, pharmaceutical and diagnostic industries.
Out of 114 applications, 17 were selected to make oral presentations after review by a panel of angel and venture capital investors and industry experts. This forum led to new relationships with some potential investors and strategic partners.
For additional information see: http://sbir.cancer.gov/investorforum/
(Presentation) Presented two posters at the 2014 International Society for the Study of Xenobiotics
(Presentation) Presented at the 2014 Personalized Medicine World conference 2014 – http://2014sv.pmwcintl.com/program.php
(Poster and Oral) Hah, S. S.; Henderson, P. T. “Kinetics of carboplatin-DNA binding in genomic DNA and bladder cancer cells as determined by accelerator mass spectrometry,” the 232th National Meeting of the American Chemical Society, San Francisco, CA, September 10-14, 2006 (presenter: Sang Soo Hah).
(Poster) Hah, S. S.; Henderson, P. T. “Biomedical applications of accelerator mass spectrometry: Kinetics of carboplatin-DNA binding in genomic DNA and bladder cancer cells,” the 37th Annual Meeting of the Environmental Mutagen Society, Vancouver, British Columbia, Canada, September 16-20, 2006 (presenter: Sang Soo Hah).
(Oral) Sang Soo Hah, Rhoda A. Sumbad, Ralph W. de Vere White, Kenneth W. Turteltaub, Chong-Xian Pan and Paul T. Henderson “Characterization of Oxaliplatin-DNA Adduct Formation in Naked DNA and Cancer Cells Using Accelerator Mass Spectrometry” UC Davis Cancer Center’s 13th Annual Cancer Research Symposium on September 28, 2007.
(Poster) Kinetics and characterization of oxaliplatin-DNA adduct formation in naked DNA and cancer cells using accelerator mass spectrometry
Author(s): Hah, SS; Sumbad, RA; Turteltaub, KW, et al. CHEMICAL RESEARCH IN TOXICOLOGY Volume: 20 Issue: 12 Pages: 1996-1996 Published: 2007
Meeting Abstract: 35
(Poster) Towards personalized chemotherapeutics: Exploring variations in DNA damage/repair in cells and tumors treated with carboplatin using accelerator mass spectrometry
Author(s): Henderson, PT; Li, T; Zhang, H, et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS Volume: 49 Issue: 7 Pages: 552-552, Published: 2007
(Oral) Sang Soo Hah, Janna M. Mundt, Hyung M. Kim, Rhoda A. Sumbad, Kenneth W. Turteltaub and Paul T. Henderson “Measurement of oxidized nucleoside metabolism in MCF-7 cells at low concentrations using accelerator mass spectrometry” UC Davis Clinical and Translational Science Center Inflammation Collaborative Workshop, January 17, 2008.
(Oral) Kenneth Turteltaub and Paul T. Henderson “Biomedical Applications of Accelerator Mass Spectrometry” at the UC Davis CTSC/CBST Technologies Informational Workshop, March 18, 2008.
(Poster) Teesta Jain, Tao Li, Miaoling He, Teesta Jain, Michael A. Malfatti, Kenneth W Turteltaub, and Chong-Xian Pan and Paul T. Henderson “Application of Accelerator Mass Spectrometry to Breast Cancer Research, UC Davis CBST Annual Meeting, UC Davis, March, 2009.
(Poster) “Preclinical oxaliplatin microdosing studies for personalized medicine applications” Chong-Xian Pan, Tao Li, Miaoling He, Teesta Jain, Michael A. Malfatti, Kenneth W. Turteltaub, and Paul T. Henderson, annual meeting of the American Society of Clinical Oncology, Orlando, FL, May 29, 2009.
(Peer-Reviewed Publication) Hah, S.S.; Stivers, K.M.; de Vere White, R.; Henderson, P.T. Kinetics of Carboplatin-DNA Binding in Genomic DNA and Bladder Cancer Cells As Determined by Accelerator Mass Spectrometry, Chemical Research in Toxicology, 2006, 19, 622-626.
(Peer-Reviewed Publication) Hah, S.S.; Sumbad, R.A.; de Vere White, R.; Turteltaub, K.W.; Henderson, P.T. Characterization of Oxaliplatin-DNA Adduct Formation in DNA and Differentiation of Cancer Cell Drug Sensitivity at Microdose Concentrations, Chemical Research in Toxicology 2007, 20(12), 1745-1751.
(Peer-Reviewed Publication) Hah SS, Henderson, PT, Turteltaub KW Towards biomarker-dependent individualized chemotherapy: Exploring cell-specific differences in oxaliplatin-DNA adducts distribution using accelerator mass spectrometry. Bioorganic and Medicinal Chemistry Letters 2010, Apr 15;20(8):2448-51.
(Peer-Reviewed Publication) Henderson PT, Pan C-X, Microdosing for prediction of patient response. Bioanalysis, 2010, 2(3), 373–376.
(Peer-Reviewed Publication) Henderson PT, Li T, He M, Zhang H, Malfatti M, Gandara D, Grimminger PP, Danenberg KD, Beckett L, de Vere White RW, Turteltaub KW, Pan CX. A microdosing approach for characterizing formation and repair of carboplatin-DNA monoadducts and chemoresistance International Journal of Cancer 2011 Sep 15;129(6):1425-34.